Stay updated with breaking news from Sarepta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citigroup assumed coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a report published on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $113.00 price target on the biotechnology company’s stock. A number of other brokerages have also recently weighed in on SRPT. Barclays dropped their price target on […]
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET PPI; 2;00ET FOMC Rate Decision ECB, BOE, SNB policy meetings Thursday - PPI 0.0% MoM, Exp. 0.0%; PPI Core 0.0% MoM, Exp. 0.2% TODAY’S HIGHLIGHTS: ~90 Percent of Moscow's Pre-War Army Lost to Death or Injury, US Intelligence Estimate Says The United
Acadian Asset Management LLC reduced its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 49.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 498 shares of the biotechnology company’s stock after selling 494 shares during the period. Acadian Asset Management LLC’s holdings in Sarepta Therapeutics were worth $57,000 […]
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Chicago Fed National Activity Index, Philadelphia Fed Non-Manufacturing Activity; 10:00ET Existing Home Sales; 1:00ET $15 billion 10-year TIPS auction; 2:00ET FOMC Meeting Minutes TODAY’S HIGHLIGHTS: ISRAEL-HAMAS DEAL ON 50 HOSTAGES CAN BE ANNOUNCED TODAY: CNN World stocks were subdued as
Van Riebeeck Hall was packed to the brim last Thursday evening (9 November) when Mayor Geordin Hill-Lewis and representatives of all City of Cape Town directorates were in town.